Prescription drug · ANDA
Dimethyl Fumarate NDC 43598-429
Dimethyl fumarate 120 mg/1 · Capsule, Delayed release · Oral · Dr. Reddy's Laboratories Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43598-429-52 | 4359804295243598042952 | 1 BOTTLE in 1 CARTON (43598-429-52) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLEMarketed from Sep 25, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dimethyl Fumarate
- Generic name (nonproprietary)
- dimethyl fumarate
- Active ingredients
- Dimethyl fumarate — 120 mg/1
- Dosage form
- Capsule, Delayed release
- Route
- Oral
- Labeler
- Dr. Reddy's Laboratories Inc.NDC labeler code 43598
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210460
- Marketing start
- Listing expires
- Identifiers
- Product ID 43598-429_fcfea8cf-7720-664c-345c-b8baeff438eeSPL ID fcfea8cf-7720-664c-345c-b8baeff438eeSPL set ID b00dcf89-59d3-9ab2-fd9b-16b9ec2d677bRxCUI 1373483, 1373491UNII FO2303MNI2
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443598042952followed by a unit qualifier and the quantityPackage 43598-0429-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 43598-429
- What is NDC 43598-429?
- 43598-429 is the product NDC for Dimethyl Fumarate, Dimethyl fumarate 120 mg/1 capsule, delayed release, listed with the FDA by Dr. Reddy's Laboratories Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dimethyl Fumarate.
- What is the active ingredient?
- Dimethyl fumarate.
- Who is the labeler?
- Dr. Reddy's Laboratories Inc., NDC labeler code 43598. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dimethyl Fumarate?
- 45 other product NDCs are listed under this name. See all Dimethyl Fumarate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dimethyl Fumarate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dimethyl Fumarate | — | Kit | Macleods Pharmaceuticals Limited | 33342-579 | 33342-0579-96 |
| Dimethyl fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | CivicaScript LLC | 82249-745 | 82249-0745-14 |
| Dimethyl fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | CivicaScript LLC | 82249-747 | 82249-0747-60 |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | Macleods Pharmaceuticals Limited | 33342-349 | 33342-0349-0933342-0349-9433342-0349-97 |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | Macleods Pharmaceuticals Limited | 33342-350 | 33342-0350-0933342-0350-95 |
| Dimethyl Fumarate | — | Kit | Macleods Pharmaceuticals Limited | 33342-351 | 33342-0351-93 |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | Quallent Pharmaceuticals Health LLC | 82009-138 | 82009-0138-60 |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | SOLA Pharmaceuticals, LLC | 70512-852 | 70512-0852-14 |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | SOLA Pharmaceuticals, LLC | 70512-853 | 70512-0853-60 |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | Aurobindo Pharma Limited | 59651-083 | 59651-0083-14 |
Other NDCs under ANDA 210460
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | Dr. Reddy's Laboratories Inc. | 43598-430 |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | MSN LABORATORIES PRIVATE LIMITED | 69539-042 |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | MSN LABORATORIES PRIVATE LIMITED | 69539-043 |
| Dimethyl Fumarate | — | Kit | MSN LABORATORIES PRIVATE LIMITED | 69539-240 |